$CTRN - Reports Q3 (Oct) loss of $0.08 per share, excluding non-recurring items, $0.03 worse than the Capital IQ Consensus Estimate of ($0.05); revenues rose 7.8% year/year to $156.7 mln vs the $153.57 mln consensus.
Hit counter provided by website-hit-counters.com website. |